Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENACT: NA-1 in patients undergoing endovascular repair of brain aneurysms
NCT00728182Phase 2Completed
- Sponsor
- NoNO Inc.
- Start
- Aug 2008
- Primary completion
- Apr 2011
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of nerinetide in ischemic stroke, sponsored by NoNO Inc.. Started Aug 2008; status: completed.
02
Drugs
nerinetide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00728182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728182.